Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P43026 (lipopolysaccharide)
 62,215 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

In vitro growth and differentiation of granulocyte-macrophage progenitor cells (GM-CFU-C) requires colony-stimulating factors (CSF), and an in vivo role for CSF has also been proposed. Prostaglandins of the E series (PGE) have been reported to serve as negative feedback regulators of myelopoiesis. Here, we report evidence of augmented CSF secretion by mouse peritoneal Mo (macrophages) and bone marrow cells in vitro upon stimulation with various biological response modifiers (BRMs). Optimal induction of CSF secretion occurred after in vitro treatment of peritoneal Mo and mononuclear bone marrow cells with 50 micrograms/ml poly ICLC (polyriboinosinic-polycytidylic acid poly-L-lysine). 5 micrograms/ml lipopolysaccharide (LPS), or 500 U/ml interferon (IFN alpha,beta) for 2 days. The in vitro stimulation of CSF secretion was paralleled by an increase in PGE secretion by Mo and bone marrow cells. The PGE secretion could, however, be selectively blocked by preincubating the cells for 3 h with indomethacin (10(-7) Mol) leaving CFS production intact. In vivo treatment of mice with either maleic anhydride divinyl ether copolymer (MVE-2; 25 mg/kg) or poly ICLC (2 mg/kg) significantly increased levels of CSF in serum, as well as in culture supernatants of in vivo-treated peritoneal Mo and bone marrow cells. The increase in serum CSF levels and in secretion of CSF by peritoneal Mo and bone marrow cells was followed by a dose-dependent increase in GM-CFU-C, in nucleated bone marrow cells, and in peripheral blood leukocytes. The same BRMs also stimulated the secretion of PGE by in vivo-activated peritoneal Mo, but not by bone marrow cells. Pretreatment of the mice with indomethacin (4 mg/kg) almost completely suppressed PGE secretion by peritoneal Mo, but did not change the CSF secretion by peritoneal Mo or bone marrow cells and had no significant effect on bone marrow cellularity. Therefore, MVE-2 and poly ICLC, in addition to their immunomodulatory activity, can also have stimulatory effects on myelopoiesis, presumably mediated through secretion of CSFs. Protection and/or restoration of bone marrow function could thus either provide the opportunity for more extensive chemotherapy or could increase the number of Mo effector cells available for activation against tumor targets.
 ...
PMID:Comparison of in vitro and in vivo modulation of myelopoiesis by biological response modifiers. 633 54

Serum from mice treated with bacterial lipopolysaccharide (LPS) was fractionated by Con A-Sepharose affinity chromatography, and assayed in vitro for colony-stimulating factor (CSF) using mouse bone marrow cells. The CSF failing to bind to concanavalin A-Sepharose (pool A) had similar biological properties to the unfractionated serum, i.e., it stimulated the formation of about equal numbers of granulocytic, mixed granulocyte-macrophage and macrophage colonies. The fraction eluted from the Con A-Sepharose column with alpha-methyl-D-glucopyranoside (pool B) had a steeper dose-response curve than either the unfractionated serum or the pool A CSF and most of the colonies were composed of macrophages. A mixture of the pool A and pool B CSFs stimulated colonies in a similar way as unfractionated serum and poolA. The apparent molecular weights of the two types of CSF were determined by two different gel-filtration procedures. Sephacryl S-200 gel-filtration suggested an apparent molecular weight of 85,000 for pool A CSF and 180,000 for pool B CSF. Gel-filtration on Sepharose CL-6B in the presence of guanidine hydrochloride (6M) yielded an apparent molecular weight of approximately 23,000 for pool A CSF and 33,000 for pool B CSF. The colony-forming cells (CFC) responding to pool B CSF were found to have a relatively high sedimentation velocity (peak sedimentation velocity 5.6--6.2 mm/hr) compared to the CFC responding to mouse-lung conditioned medium (MLCM) whose peak sedimentation velocity was between 4.0--4.5 mm/hour. The CFC responding to pool A CSF had an intermediate sedimentation velocity (peak 4.6--5.2 mm/hour). A time-course analysis of the morphology of clones or colonies in cultures stimulated with either MLCM or pool B CSF showed that the proportion of different colony types depends significantly on the incubation period and suggested that pool tb csf induced an early commitment of CFC towards macrophages differentiation.
 ...
PMID:Serum of lipopolysaccharide-treated mice contains two types of colony-stimulating factor, separable by affinity chromatography. 696 84

The production of macrophage-activating factor (MAF) by antigen-stimulated murine T lymphocyte clones has been compared with their cytolytic function and release of other lymphokines. MAF activity was measured by the capacity of peptone-induced peritoneal exudate cells or bone marrow-derived macrophages to lyse 51Cr-labeled tumor cells after incubation with supernatant from the stimulated T cells and a nonactivating, amplifying dose of lipopolysaccharide. Of 72 clones generated against H-2, MIs, H-Y, or Moloney leukemia virus-associated antigens, 68 were found to produce detectable quantities of MAF. Release of MAF by clones 1) occurred within 1 to 12 hr of exposure to antigen, 2) required stimulation with cells of the relevant antigenic specificity, and 3) could also be induced by concanavalin A, indicating that the cloned cells were the source of the activity. The capacity of a clone to produce MAF was independent of its antigenic specificity, cytolytic activity, or ability to produce interleukin 2 or granulocyte-macrophage colony-stimulating activity. In contrast, production of interferon and MAF was not dissociated for any of the clones tested.
 ...
PMID:Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities. 704 27

The in vivo effect of Nocardia rubra cell-wall skeleton (N-CWS) was studies on the generation of bone marrow granulocyte-macrophage progenitor cells [colony-forming units culture (CFU-c)] and on the levels of myeloid colony-stimulating activity (CSA) in the conditioned medium of the lung (LCM) and serum obtained from mice. In vitro bone marrow culture showed that intraperitoneal (ip) treatment of mice with N-CWS markedly enhanced CFU-c formation induced by stimuli in LCM or serum derived from lipopolysaccharide (LPS)-treated mice. The LCM and serum of mice injected with N-CWS ip were also prepared and assayed for CSA. CSA levels with N-CWS-LCM as well as LPS-LCM used as the standard CSA were markedly greater than those achieved with control LCM. N-CWS-serum also showed a low but significant level of CSA. The CSA level of N-CWS-LCM was maximal at 3 to 5 days after N-CWS injection. These results raise the possibility that enhanced CSA production might be a major mechanism for N-CWS stimulation of granulocyte-macrophage production.
 ...
PMID:Effect of Nocardia rubra cell-wall skeleton on colony-stimulating activity and myeloid colony formation. 712 5

Inbred mouse strains C57BL/10Sn (Sn) and C57BL/10ScN (ScN) differ in response of their hematopoietic system to injection of lipopolysaccharide-W (LPS-W) in a manner similar to that observed for the LPS unresponsive C3H/HeJ and the paired responsive C3H/HeN strain mice. Responses of endogenous (E-CFU) stem cells as well as bone marrow and spleen-derived exogenous (CFU-s) stem cells, granulocyte-macrophage (GM-CFC) and macrophage (M-CFC) colony-forming cells were determined for Sn and ScN strain mice following an intraperitoneal injection of 10 micrograms LPS-W. Sn strain mice responded characteristically in terms of every parameter measured. Marrow-derived parameters reflected release of nucleated cells and early decrease of CFU-s, GM-CFC, and M-CFC followed by return toward control values. Peak splenic responses were observed within 4-5 days, whereas E-CFU increased significantly within 24 h after LPS-W. These responses were in marked contrast to those observed for the ScN strain mice, which were relatively unresponsive in terms of each parameter measured after LPS-W injection. These results show that the phenotypic expression of the defective LPS locus recently described in the ScN strain mice extends to those cells that control the response of the hematopoietic system to LPS, and is similar in every respect to those responses observed for the mutant LPS defective, C3H/HeJ strain mice.
 ...
PMID:Hematopoietic responses to lipopolysaccharide in C57BL/10Sn and C57BL/10ScN strain mice. 715 81

The paired, inbred mouse strains C3HeB/FeJ and C3H/HeJ differ in their extramedullary hemopoietic response to lipopolysaccharide (LPS). The C3H/HeJ exhibit reduced responses relative to the C3HeB/FeJ in terms of colony-stimulating factor, endogenous and exogenous spleen-derived stem cells (CFUS), and spleen-derived granulocyte-macrophage colony-forming cells (GM-CFC) whereas equivocal responses were noted for the marrow-derived CFUS and GM-CFC. In an effort to determine if the mutational defect was specifically limited to extramedullary expression, we utilized C3HeB/FeJ mice and C3H/HeJ mice at 6 weeks postsplenectomy. The splenectomy emphasizes the medullary response to an i.p. injection of 10 microgram Escherichia coli, LPS-W. Significant differences were revealed in the responses of C3HeB/FeJ and C3H/HeJ marrow-derived cells. Total cells, CFUS, GM-CFC, and the macrophage colony-forming cell (M-CFC) in the C3HeB/FeJ strain all decreased significantly from their saline-injected control values as well as from their counterpart C3H/HeJ values within 48 h after injection of LPS-W. The decline in C3HeB/FeJ CFUS, GM-CFC, and M-CFC was followed by an overshoot, with subsequent return to control values. The total nucleated cells, CFUs, GM-CFC, and M-CFC derived from the C3H/HeJ marrow were characteristically nonresponsive and never varied significantly from their saline-injected control values over the observation period. These results suggest that the phenotypic effect of the defective gene can extend to all hemopoietic tissue, medullary and extramedullary, that normally respond to the factors released through expression of the LPS locus.
 ...
PMID:Hematopoietic response of splenectomized C3HeB/FeJ and C3H/HeJ mice to lipopolysaccharide. 733 73

A new screening method for inducers of colony-stimulating factors (CSFs) was established using KM-102, a human bone marrow stromal cell line as the producer. In this method, the assay system which uses CSF dependent cell lines is combined with the CSF production system. Interleukin-1 (IL-1), which is known to upregulate CSF production in many cell populations, was used as a positive control for production of granulocyte CSF (G-CSF) and granulocyte-macrophage CSF (GM-CSF). Induction in the positive controls was clearly detected within 24 hours. Activators of protein kinase C (PKC), protein phosphatase inhibitors and lipopolysaccharide (LPS) were positive in this assay system, but muramyl dipeptide (MDP) and Bestatin which are known macrophage activators, were negative. Inducers of CSFs were successfully detected using this assay method. Among 1,600 microbial strains tested, 2 actinomycete strains were found to produce active substances. One strain produces teleocidin-A, a strong activator of PKC, and the other strain produces a mixture of active compounds including three novel compounds. These three compounds do not induce terminal differentiation of HL-60 cells, suggesting that they are not teleocidin-like substances and form a new class of CSF inducers.
 ...
PMID:Screening method for colony-stimulating factor inducers using a human bone marrow stromal cell line, KM-102. 750 74

During the administration of recombinant human granulocyte colony-stimulating factor (rhG-CSF) or granulocyte-macrophage CSF (rhGM-CSF) we studied the early and late changes of membrane antigen density on neutrophils. RhG-CSF and rhGM-CSF both caused an early transient reduction in blood neutrophilic granulocyte-concentration within the first 30 min after treatment followed by a marked later increase during the subsequent 24 h. During the early neutropenia quantitative flow cytometry showed an associated marked increase in the density of membrane CD11b from 169 x 10(3) before to 568 x 10(3) A.U. per cell induced by rhGM-CSF but a non-significant change by rhG-CSF, suggesting that different mechanisms may be responsible for the transient neutropenia. The subsequent neutrophil granulocytosis was followed by a significantly (P < 0.05) increased density of the CD14 antigen from 6.1 x 10(3) before to 15.9 x 10(3) A.U. per cell during treatment with rhG-CSF, but not by rhGM-CSF administration. These results demonstrate that the two cytokines may affect the function of neutrophilic granulocytes in different ways. The increased expression of CD11b could explain some of the side-effects during treatment with rhGM-CSF. The upregulation of CD14 induced by rhG-CSF may be clinically relevant, as CD14 is an opsonic receptor for lipopolysaccharide binding proteins, acting in the defence against Gram-negative bacterial infections.
 ...
PMID:Different membrane expression of CD11b and CD14 on blood neutrophils following in vivo administration of myeloid growth factors. 750 10

Cytomegalovirus (CMV) infection is frequently associated with graft failure in bone marrow transplant patients; the pathogenesis of this myelosuppression in not clearly understood. We have previously documented that CMV-induced myelosuppression is related to an alteration of the marrow microenvironment. To further investigate the effect of CMV on stromal cell function, conditioned media (CM) from CMV-infected or uninfected stromal cells were tested for their capacity to promote the growth of granulocyte/macrophage colony-forming cells (CFU-GM) and for their concentration in colony-stimulating factors (CSFs) such as interleukin-3 (IL-3), IL-6, granulocyte-macrophage and granulocyte colony-stimulating factors (GM-CSF and G-CSF). CM from CMV-infected stromal cells failed to sustain granulocyte-macrophage colony-forming unit (CFU-GM) growth. The production of IL-6, GM-CSF, and G-CSF, measured by enzyme-linked immunosorbent assay (ELISA), was 21,150 +/- 3392, 57 +/- 15, and 2340 +/- 717 pg/mL, respectively, in CMV-infected stromal cells stimulated by lipopolysaccharide (LPS) and was significantly decreased (p < 0.01) from the control values (177,138 +/- 98,692, 113 +/- 20, and 5533 +/- 1306 pg/mL). These results suggest that the myelosuppressive effect of CMV is primarily due to a lack of CSF production. To further document this hypothesis, primitive marrow progenitor cells (blast colony-forming cells [Bl-CFC]) cultured on CMV-infected stromal layer have been grown in the presence of IL-3 (20 ng/mL), IL-6 (20 ng/mL), GM-CSF (40 ng/mL), and G-CSF (50 ng/mL). Used alone, all these CSFs partially reverse the CMV-induced inhibition of Bl-CFC growth; the combination of these CSFs completely restores normal Bl-CFC values. These data strongly suggest that CMV-induced myelosuppression is related to the lack of CSF production by the cells of the marrow microenvironment.
 ...
PMID:Decreased production of cytokines after cytomegalovirus infection of marrow-derived stromal cells. 750 72

Chronic idiopathic neutropenia is an uncommon condition characterized by a low level of neutrophils without any causative disease. We report the details of 4 patients whose stromal cytokine mRNA expressions were examined by reverse transcription polymerase chain reaction. Three patients showed a lower expression of granulocyte colony-stimulating factor (G-CSF) mRNA both in constructive and lipopolysaccharide (LPS)-induced conditions and normal colony forming unit-granulocyte-macrophage (CFU-GM) from the bone marrow cells. One patient showed an increase of G-CSF mRNA and a decrease of CFU-GM. No abnormal expression of other cytokines including interleukin (IL)-1 beta, IL-6 and IL-8 were observed. These findings indicate that cytokine mRNA analysis of stromal cells is useful for elucidation of the etiology.
 ...
PMID:Chronic idiopathic neutropenia associated with abnormal expression of granulocyte colony-stimulating factor mRNA of bone marrow stromal cells. 751 24


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>